These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20633181)

  • 41. Cervical dystonia: from pathophysiology to pharmacotherapy.
    Patel S; Martino D
    Behav Neurol; 2013; 26(4):275-82. PubMed ID: 22713419
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxins in dentistry--the new paradigm for masticatory muscle hypertonicity.
    Katz H
    Singapore Dent J; 2005 Dec; 27(1):7-12. PubMed ID: 16438262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bilateral Lower Sternocleidomastoid Botulinum Toxin Injections to Address Refractory Anterocollis.
    Peng-Chen Z; Thompson A; Rodriguez RL
    Neurologist; 2016 Mar; 21(2):30-1. PubMed ID: 26926853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pyridostigmine for reversal of severe sequelae from botulinum toxin injection.
    Young DL; Halstead LA
    J Voice; 2014 Nov; 28(6):830-4. PubMed ID: 25008379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
    Factor SA; Molho ES; Evans S; Feustel PJ
    Mov Disord; 2005 Sep; 20(9):1152-60. PubMed ID: 15954134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time course of distant effects of local injections of botulinum toxin.
    Garner CG; Straube A; Witt TN; Gasser T; Oertel WH
    Mov Disord; 1993; 8(1):33-7. PubMed ID: 8380486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Case report: Physical therapy management of axial dystonia.
    Voos MC; Oliveira Tde P; Piemonte ME; Barbosa ER
    Physiother Theory Pract; 2014 Jan; 30(1):56-61. PubMed ID: 23848574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
    Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
    Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
    [No Abstract]   [Full Text] [Related]  

  • 49. Botulinum toxin: a new dimension in the treatment of lower urinary tract dysfunction.
    Rajkumar GN; Conn IG
    Urology; 2004 Jul; 64(1):2-8. PubMed ID: 15245922
    [No Abstract]   [Full Text] [Related]  

  • 50. Cervical dystonia pathophysiology and treatment options.
    Velickovic M; Benabou R; Brin MF
    Drugs; 2001; 61(13):1921-43. PubMed ID: 11708764
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment with botulinum toxin in a patient with myasthenia gravis and cervical dystonia.
    Fasano A; Bentivoglio AR; Ialongo T; Soleti F; Evoli A
    Neurology; 2005 Jun; 64(12):2155-6. PubMed ID: 15985599
    [No Abstract]   [Full Text] [Related]  

  • 52. [Cervical dystonia--diagnosis and treatment].
    Skogseid IM
    Tidsskr Nor Laegeforen; 2008 Oct; 128(19):2202-5. PubMed ID: 18846145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluoroscopic, EMG-guided injection of botulinum toxin into the longus colli for the treatment of anterocollis.
    Glass GA; Ku S; Ostrem JL; Heath S; Larson PS
    Parkinsonism Relat Disord; 2009 Sep; 15(8):610-3. PubMed ID: 19250855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Spasmodic torticollis: experience of 5 years with botulinum toxin treatment].
    Domzał TM
    Neurol Neurochir Pol; 1999; 33(2):351-7. PubMed ID: 10463249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Facial anatomy and botulinum toxin: the muscular balances].
    Trevidic P; Cauchois R; Ingallina F
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S61-6. PubMed ID: 19576487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Role of Ultrasound for the Personalized Botulinum Toxin Treatment of Cervical Dystonia.
    Fietzek UM; Nene D; Schramm A; Appel-Cresswell S; Košutzká Z; Walter U; Wissel J; Berweck S; Chouinard S; Bäumer T
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34065541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm.
    Med Lett Drugs Ther; 2010 Nov; 52(1351):90-1. PubMed ID: 21068703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials.
    Lew MF; Brashear A; Factor S
    Neurology; 2000; 55(12 Suppl 5):S29-35. PubMed ID: 11188982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anatomo-sonographic identification of the longissimus capitis and splenius cervicis muscles: principles for possible application to ultrasound-guided botulinum toxin injections in cervical dystonia.
    Brumpt E; Aubry S; Vuillier F; Tatu L
    Surg Radiol Anat; 2021 Jun; 43(6):909-915. PubMed ID: 33459837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.